Exome Asset Management »

Legend Biotech 2 Adr Rep Ord shares owned by Exome Asset Management

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3M 47k 48.73
2023-12-31 $2.3M 38k 60.17

More positions owned by Exome Asset Management

Eli Lilly & Co. (LLY)
Ascendis Pharma A/s Sponsored Adr (ASND)
Bridgebio Pharma (BBIO)
Structure Therapeutics Sponsored Ads (GPCR)
Tg Therapeutics (TGTX)
Align Technology (ALGN)
Cigna Corp (CI)
Gilead Sciences (GILD)
Geron Corporation (GERN)
Biontech Se Sponsored Ads (BNTX)
Bristol Myers Squibb (BMY)
Miragen Therapeutics (VRDN)
Intuitive Surgical Com New (ISRG)
Beigene Sponsored Adr (BGNE)
Blueprint Medicines (BPMC)

View all positions for Exome Asset Management

Top funds holding Legend Biotech 2 Adr Rep Ord

T. Rowe Price Associates
RA Capital Management
Hillhouse Capital Advisors
BlackRock
Westfield Capital Management Company
BlackRock
Henderson Group
Invesco
Massachusetts Financial Services
Capital Research and Management Company - Division 3
Braidwell
Federated Investors
Citadel Advisors
TimesSquare Capital Management
State Street Corporation

View all funds holding Legend Biotech 2 Adr Rep Ord